IDH1 and central nervous system cancer: In cartilaginous tumors of patients with enchondromatosis, the expression of the IDH1 R132C mutation is more common than IDH1 R132H (70% vs. 15%, respectively) [38,42], whereas IDH1 R132H represents the main mutation (90%) in sporadic IDH mutant gliomas [36].